HIV

Birmingham AIDS Outreach, Binx Health launch accessible HIV/STI testing program in Alabama
The program will serve the Birmingham, AL, metro area by providing access to self-collection kits for HIV and sexually transmitted infections (STIs) through a network of trusted partners that work with higher-risk populations.
March 1, 2023
Blood Test Samples Lab Social
Roche, CDC expand partnership on HIV and TB support for healthcare systems in critical regions
The public-private partnership, named Lab Networks for Health, aims to improve HIV and TB detection, prevention, and treatment in countries that have been hit hardest by the two diseases.
February 28, 2023
Bacteria Mycobacterium Tuberculosis Social
Chembio Diagnostics obtains FDA CLIA waiver for HIV-syphilis testing system
More than 200,000 CLIA-waived point-of-care testing sites in the U.S. can now use the system to detect HIV and syphilis, Richard Eberly, Chembio’s president and CEO, said in a statement.
February 24, 2023
Hiv Virions Cdc Social
Maternova, MedMira ink agreement to market rapid diagnostic tests for HIV, syphilis, hepatitis
MedMira's Multiplo TP/HIV rapid test delivers 100% sensitivity in identifying co-infections and is helping to reduce mother-to-child transmission of syphilis and HIV, the firms said.
February 21, 2023
Lab Hiv Test Social
Thermo Fisher Scientific launches sequencing assay to ID variants that may resist HIV therapies
The assay, which uses HIV RNA extracted from plasma or dried blood spots, is designed to analyze genomic mutations in the protease, reverse transcriptase, and integrase regions of the HIV-1 pol gene across nine subtypes of global significance.
January 24, 2023
Lab Hiv Test Social
Chembio Diagnostics applies for FDA CLIA waiver for HIV, syphilis test
Using a small blood sample, the test detects antibodies for HIV types 1 and 2 as well as Treponema pallidum, the bacteria that causes syphilis.
November 28, 2022
Infectious Diseases Research Social
Most Popular
Quest launches long-COVID testing panels for consumers
Ohio, Kentucky doctors convicted in scheme to bill Medicaid for millions of dollars in unnecessary urinalysis testing
RNA-seq analysis links protein to spread of pancreatic cancer, reveals potential drug target
LumiraDx Q4 revenues drop 65% on lower COVID-19 testing
Patients prefer immediate test results, even when the news is bad
Point-of-care test developer Proxim Diagnostics obtains strategic investment from BioMérieux
G Medical Innovations to provide numerous at-home testing kits to consumers
The tests include screening for monkeypox, colon cancer, thyroid issues, and sexually transmitted diseases (STDs) such as HIV and syphilis, as well as tests for many other health issues, the company said.
October 7, 2022
Fingerprick Blood
Week in Review: Roche’s new MDx system, HIV world market, cervical cancer testing disparities, and more
Dear LabPulse.com member,
August 24, 2022
Kalorama Information values 2021 HIV testing market at $2.597B
Of the different types of tests, HIV immunoassays are expected to see a compound annual growth rate (CAGR) of 3.2% from 2021 through 2026, said the report, which is published by LabPulse.com's sister brand Kalorama Information.
August 18, 2022
2019 06 24 22 49 6342 Lab Hiv Test 400
Thermo Fisher releases RUO assay for HIV variants
Specifically, the assay analyses HIV RNA extracted from ethylenediaminetetraacetic acid (EDTA) plasma or dried blood spots to measure genomic mutations in the protease, reverse transcriptase, and integrase regions of the pol gene.
August 7, 2022
2019 06 24 22 49 6342 Lab Hiv Test 400
Gilead offers $24M in grants to address HIV disparities
The grants will support 116 organizations in 41 countries and aim to improve access to quality healthcare and advance medical education in targeted communities. Organizations granting Zeroing In program funds will specifically prioritize populations most affected by the HIV epidemic, with a focus on collaboration with local communities, the company said in a release.
March 31, 2022
2021 01 08 23 53 2466 Business Hands Cooperation 400
Severe COVID-19 risk linked to lower HIV risk
The variant in question, which is associated with severe COVID-19, is located on chromosome 3 in a region that encodes for chemokine receptors. Individuals who carry the factor have decreased levels of the chemokine receptors CCR3, CCR5, and CXCR6, which was the clue to the link with HIV infection, since low values of these three receptors are associated with a lower prevalence of HIV infection, according to the paper's author, Hugo Zeber, PhD, of the Max Planck Institute for Evolutionary Anthropology.
February 24, 2022
2022 02 22 23 25 2921 Covid Dna Sequencing 400
Page 1 of 3
Next Page